NDC 43857-0180-01 - FEMALE BALANCE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43857-0180
- Requested NDC
- 43857-0180-01
- Package NDCs from labels
- 43857-0180-1, 43857-0180-01
- Manufacturer
- BioActive Nutritional, Inc. | Apotheca Company
- Effective date
- 2026-05-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FEMALE BALANCE - BioActive Nutritional, Inc. | Apotheca Company | BioActive Nutritional, Inc. | Apotheca Company | 2026-05-14 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43857-0180-1 | FEMALE BALANCE | 30 mL in 1 BOTTLE, SPRAY | LIQUID | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43857-0180 | FEMALE BALANCE (FOLLICULINUM, PROGESTERONE) LIQUID [BIOACTIVE NUTRITIONAL, INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20211210_78ad2598-3e80-4571-81cb-7bd50d770153.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Progesterone | PROGESTERONE | Amneal Pharmaceuticals LLC | 4de0715d-a3b9-42fa-b4e4-6371151fd75c | 2026-02-24 | Warnings, Adverse reactions | 4G7DS2Q64Y |
| Female Stimulant | ACONITICUM ACIDUM, CIS-, APIS VENENUM PURUM, AQUILEGIA VULGARIS, BOVISTA, CYPRIPEDIUM PUBESCENS, ESTRADIOL, FAECALIS (ALKALIGENES), FOLLICULINUM, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEART (SUIS), HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, KREOSOTUM, LACHESIS MUTUS, LILIUM TIGRINUM, MAGNESIA PHOSPHORICA, MERCURIUS SOLUBILIS, MUTABILE BACILLUS (BACH), OOPHORINUM (SUIS), PETROSELINUM SATIVUM, PINEAL GLAND (SUIS), PLACENTA TOTALIS SUIS, PROGESTERONE, SEPIA, TESTOSTERONE, UTERUS (SUIS) | Deseret Biologicals, Inc. | 0d4b8cbf-8f57-43ca-a904-c69d9056c865 | 2026-02-19 | Warnings | 2DI9HA706A 4G7DS2Q64Y |
| Progesterone | PROGESTERONE | Northstar Rx LLC | 73229a76-8de3-4cea-886f-568f0b817fea | 2026-02-19 | Warnings, Adverse reactions | 4G7DS2Q64Y |
| Progesterone | PROGESTERONE | Xiromed, LLC | 0bf317a8-96d6-849d-7850-9084205a5315 | 2026-02-17 | Warnings, Adverse reactions | 4G7DS2Q64Y |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| PROGESTERONE | PROGESTERONE | Proficient Rx LP | 199c8575-e113-468f-8eb7-c4930030649c | 2026-02-01 | Boxed warning, Warnings, Adverse reactions | 4G7DS2Q64Y |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| PROGESTERONE | PROGESTERONE | Bryant Ranch Prepack | 46d97ca6-970f-478f-81ff-1b9a9f6cb2f7 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 4G7DS2Q64Y |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| Progesterone | PROGESTERONE | Preferred Pharmaceuticals Inc. | eca6a7c0-7f58-4dcf-aec0-9d44fd594aa1 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 4G7DS2Q64Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.